Eli Lilly Prevails in Cymbalta Labeling Trial

Eli Lilly Prevails in Cymbalta Labeling Trial

A federal jury in California returned a verdict for Eli Lilly & Co. in a case brought by a woman who claimed that the company understated the withdrawal risks of its antidepressant Cymbalta. [8/10/15]

Search